Skip to main content
DBD
NYSE Technology

10% Owner Sells $33M in Diebold Nixdorf Stock Near 52-Week High

Analysis by Wiseek.ai
Sentiment info
Negative
Importance info
7
Price
$84.78
Mkt Cap
$2.982B
52W Low
$36.425
52W High
$85.99
Market data snapshot near publication time

summarizeSummary

Millstreet Capital Management and its managing members, a 10% owner of Diebold Nixdorf, sold over $32.9 million worth of common stock, reducing their stake while the stock trades near its 52-week high.


check_boxKey Events

  • Significant Insider Sale

    Millstreet Capital Management LLC, a 10% owner, along with managing members Brian D Connolly and Craig Kelleher, disposed of 399,929 shares of common stock.

  • Substantial Value

    The open market sale totaled $32,960,468 at an average price of $82.42 per share on April 8, 2026.

  • Position Reduction

    This transaction reduces their collective holdings to 4,816,743 shares, representing a 7.66% reduction in their prior stake.

  • Timing Near 52-Week High

    The sale occurred while Diebold Nixdorf's stock is trading near its 52-week high of $85.99, potentially indicating profit-taking.


auto_awesomeAnalysis

This significant open market sale by a 10% institutional owner, Millstreet Capital Management, and its managing members, represents a substantial disposition of shares. While not an operational insider, the sale of over $32.9 million worth of stock, equivalent to more than 1% of the company's market capitalization, indicates a notable reduction in their position. The transaction occurred with the stock trading near its 52-week high, suggesting the investors may be locking in gains. This follows Diebold Nixdorf's strong financial rebound reported in February, which included a new share repurchase program, but this sale by a major investor could introduce some selling pressure.

At the time of this filing, DBD was trading at $84.78 on NYSE in the Technology sector, with a market capitalization of approximately $3B. The 52-week trading range was $36.43 to $85.99. This filing was assessed with negative market sentiment and an importance score of 7 out of 10.

descriptionView Main SEC Filing

show_chartPrice Chart

Share this article

Copied!

feed DBD - Latest Insights

DBD
Apr 17, 2026, 4:28 PM EDT
Filing Type: SCHEDULE 13D/A
Importance Score:
7
DBD
Apr 10, 2026, 4:04 PM EDT
Filing Type: 4
Importance Score:
7
DBD
Feb 12, 2026, 4:38 PM EST
Filing Type: 10-K
Importance Score:
9
DBD
Feb 12, 2026, 7:05 AM EST
Filing Type: 8-K
Importance Score:
8
DBD
Jan 20, 2026, 4:11 PM EST
Filing Type: SCHEDULE 13D/A
Importance Score:
7
DBD
Jan 20, 2026, 4:10 PM EST
Filing Type: 4
Importance Score:
7
DBD
Jan 15, 2026, 4:40 PM EST
Filing Type: 144
Importance Score:
7